BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21211588)

  • 1. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.
    Scheible K; Zhang G; Baer J; Azadniv M; Lambert K; Pryhuber G; Treanor JJ; Topham DJ
    Vaccine; 2011 Mar; 29(11):2159-68. PubMed ID: 21211588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.
    Sridhar S; Begom S; Bermingham A; Ziegler T; Roberts KL; Barclay WS; Openshaw P; Lalvani A
    Eur J Immunol; 2012 Nov; 42(11):2913-24. PubMed ID: 22777887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.
    Bethell D; Saunders D; Jongkaewwattana A; Kramyu J; Thitithayanont A; Wiboon-ut S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Uthaimongkol N; Garcia JM; Timmermans AE; Peiris M; Thomas S; Engering A; Jarman RG; Mongkolsirichaikul D; Mason C; Khemnu N; Tyner SD; Fukuda MM; Walsh DS; Pichyangkul S
    PLoS One; 2013; 8(3):e59674. PubMed ID: 23555741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
    Gras S; Kedzierski L; Valkenburg SA; Laurie K; Liu YC; Denholm JT; Richards MJ; Rimmelzwaan GF; Kelso A; Doherty PC; Turner SJ; Rossjohn J; Kedzierska K
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12599-604. PubMed ID: 20616031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
    Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
    PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
    Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
    BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.
    Wagar LE; Rosella L; Crowcroft N; Lowcock B; Drohomyrecky PC; Foisy J; Gubbay J; Rebbapragada A; Winter AL; Achonu C; Ward BJ; Watts TH
    PLoS One; 2011; 6(11):e28063. PubMed ID: 22132212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.
    Weinfurter JT; Brunner K; Capuano SV; Li C; Broman KW; Kawaoka Y; Friedrich TC
    PLoS Pathog; 2011 Nov; 7(11):e1002381. PubMed ID: 22102819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients.
    Baluch A; Humar A; Egli A; Gubbay J; Lisboa L; Wilson L; Kumar D
    PLoS One; 2011; 6(12):e28627. PubMed ID: 22194870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
    Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
    J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.
    Chi CY; Liu CC; Lin CC; Wang HC; Cheng YT; Chang CM; Wang JR
    Clin Vaccine Immunol; 2010 Dec; 17(12):1958-62. PubMed ID: 20876823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.
    Gilbert GL; Cretikos MA; Hueston L; Doukas G; O'Toole B; Dwyer DE
    PLoS One; 2010 Sep; 5(9):e12562. PubMed ID: 20830210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.
    O'Donnell CD; Wright A; Vogel L; Boonnak K; Treanor JJ; Subbarao K
    Clin Vaccine Immunol; 2014 May; 21(5):737-46. PubMed ID: 24648486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Niño D; Wells JM; Arden N; Cheung S; Belmont JW
    Clin Infect Dis; 2012 Feb; 54(3):311-7. PubMed ID: 22075792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.